Chi-yuan Yao

No. 7, Chung Shan South Road
TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Clinicomolecular features and clonal evolution of KMT2A-PTD AML: prognostic impact of concurrent FLT3-ITD under 2022 ELN risk stratification.

Clinicomolecular features and clonal evolution of KMT2A-PTD AML: prognostic impact of concurrent FLT3-ITD under 2022 ELN risk stratification.

Journal: Blood cancer journal

Published: May 24, 2026

Clonal hematopoiesis and atherosclerotic cardiovascular disease: Clinical implications, biological mechanisms, and emerging therapeutic strategies.

Clonal hematopoiesis and atherosclerotic cardiovascular disease: Clinical implications, biological mechanisms, and emerging therapeutic strategies.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: April 27, 2026

An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.

An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.

Journal: Cancer science

Published: December 26, 2025

Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.

Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.

Journal: Blood cancer journal

Published: September 09, 2025

Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes.

Prognostic impact of lymphocyte to monocyte ratio in patients with myelodysplastic neoplasms/syndromes.

Journal: Blood research

Published: September 03, 2025

O-linked glycan-dependent gating of TPC2 controls lysosomal excitability and organelle remodeling.

O-linked glycan-dependent gating of TPC2 controls lysosomal excitability and organelle remodeling.

Journal: Nature communications

Published: August 07, 2025

Clinical Manifestations and Ophthalmic Outcomes of Leukemic Retinopathy and Optic Neuropathy in Patients With Acute Leukemia.

Clinical Manifestations and Ophthalmic Outcomes of Leukemic Retinopathy and Optic Neuropathy in Patients With Acute Leukemia.

Journal: Investigative ophthalmology & visual science

Published: August 01, 2025

Unmasking human T cell receptor germline diversity: 335 novel alleles identified in 47 Pangenome reference individuals using the gAIRR Suite.

Unmasking human T cell receptor germline diversity: 335 novel alleles identified in 47 Pangenome reference individuals using the gAIRR Suite.

Journal: Journal of advanced research

Published: August 01, 2025

Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: insights from real-world genomic data.

Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: insights from real-world genomic data.

Journal: Blood cancer journal

Published: July 19, 2025

HLA-C03:04:01 and HLA-B15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients.

HLA-C03:04:01 and HLA-B15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients.

Journal: World journal of gastroenterology

Published: July 11, 2025

Genomic and transcriptomic characterization of acute myeloid leukaemia with IL3RA overexpression: Prognostic and therapeutic implications revisited.

Genomic and transcriptomic characterization of acute myeloid leukaemia with IL3RA overexpression: Prognostic and therapeutic implications revisited.

Journal: British journal of haematology

Published: July 01, 2025

Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.

Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.

Journal: Blood cancer journal

Published: February 13, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026